Last reviewed · How we verify

NCT04243044

Influence of Transcutaneous Spinal Stimulation Intensity on Spasticity After SCI

Completed NA Last updated 7 March 2024
What this trial tests

NA trial testing Transcutaneous spinal stimulation in Spinal Cord Injuries in 21 participants. Completed in 1 December 2023.

Timeline
8 April 2022
Primary endpoint
1 December 2023
1 December 2023

Quick facts

Lead sponsorShepherd Center, Atlanta GA
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment21
Start date8 April 2022
Primary completion1 December 2023
Estimated completion1 December 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Shepherd Center, Atlanta GA

Who can join

16 and older, any sex, with Spinal Cord Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Transcutaneous spinal stimulation (TSS) is a form of electrical stimulation delivered over the skin of the spine that may be valuable for reducing spasticity without the side effects of antispasticity medications. The intensity of stimulation, or dose, that promotes the best response is not known. Understanding the response to different intensities of stimulation and how they affect spasticity will help guide rehabilitation for persons with SCI. Therefore, this study aims to identify the effects of TSS as a non-drug intervention for spasticity management.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Optimizing transcutaneous spinal stimulation: excitability of evoked spinal reflexes is dependent on electrode montage.
    Thatcher KL, Nielsen KE, Sandler EB, Daliet OJ, et al · · 2025 · cited 3× · PMID 39762915 · DOI 10.1186/s12984-024-01524-5
  2. Transcutaneous Spinal Stimulation Modulates Spinal Reflex Circuit Excitability in Persons with Spinal Cord Injury.
    Sandler EB, Iddings JA, Minassian K, Field-Fote EC. · · 2025 · cited 1× · PMID 41007758 · DOI 10.3390/biomedicines13092195
  3. Immediate Effects of Transcutaneous Spinal Stimulation on Stretch-Induced Spasticity in Persons with Spinal Cord Injury.
    Sandler EB, Iddings JA, Field-Fote EC. · · 2025 · PMID 41300207 · DOI 10.3390/brainsci15111201
  4. Optimizing Transcutaneous Spinal Stimulation: Excitability of Evoked Spinal Reflexes is Dependent on Electrode Montage
    Thatcher KL, Nielsen KE, Sandler EB, Daliet OJ, et al · · 2024 · DOI 10.21203/rs.3.rs-4719031/v1

Verify or expand the search:

Other trials of Transcutaneous spinal stimulation

Trials testing the same drug.

Other recruiting trials for Spinal Cord Injuries

Currently open trials in the same condition.

Other Shepherd Center, Atlanta GA trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04243044.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing